A new ADHD drug targets three brain chemicals instead of two. Here’s what that means
Israel Sebastian/Getty Images A new medicine for attention-deficit hyperactivity disorder (ADHD) has just entered the treatment toolbox: centanafadine, a once-a-day tablet sold under the brand name Simtriyo. It has been...
Scoring cues
blocked politics
New policy implementedBreakthrough research